Rheumatology Journal Club

October 18, 2019

Presenter:  Padmini Parameswaran, MD, PGY4 Rheumatology Fellow


Learning Objectives

  1. Compare upacatinib efficacy with adalimumab efficacy in RA patients with ineffective response to methotrexate

  2. Identify common adverse effects of JAK1 inhibitors

  3. Recognize the imitations of the study and applicability

Session date: 
10/18/2019 - 8:00am to 9:00am EDT
West Penn Hospital
4800 Friendship Avenue
Medical Library Classroom, Lower Level
Pittsburgh, PA 15224
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Please login or register to take this course.